U.S., May 3 -- ClinicalTrials.gov registry received information related to the study (NCT06956144) titled 'Exploring the Clinical Application Value of CAIX-Targeted PET Imaging in Renal Cancer Patients' on April 25.
Brief Summary: To evaluate the efficacy of targeted CAIX-specific probe PET imaging in the diagnosis and staging of kidney cancer, as well as to assess its role in prognosis prediction and treatment evaluation for kidney cancer.
Study Start Date: April 28
Study Type: OBSERVATIONAL
Condition:
Tumor
Carbonic Anhydrase IX
Recruitment Status: RECRUITING
Sponsor: The First Affiliated Hospital of Xiamen University
Disclaimer: Curated by HT Syndication....